Stay updated on Nivolumab Post Induction in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.

Latest updates to the Nivolumab Post Induction in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior Revision: v3.4.1 along with the government funding/status notice.SummaryDifference0.5%

- Check20 days agoChange DetectedA government funding status notice was added indicating possible delays and that the NIH Clinical Center is open, with links to status updates. The site revision was updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.5%

- Check28 days agoChange DetectedA new 'Show glossary' option was added. Capitalization edits were made to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the page now shows Revision: v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page, which is a minor system update with no changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new Locations section with the Gyeonggi-do site was added to the study page to indicate recruitment locations. The previous Gyeonggi-do Locations label was removed and the HHS Vulnerability Disclosure link was removed; the page revision updated to v3.3.3.SummaryDifference0.2%

- Check91 days agoChange DetectedRevision: v3.3.2 is shown on the page, replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Post Induction in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.